Management of Leukopenia in Dengue Patients

Monitoring and Management Recommendations

Daily complete blood count monitoring is essential for all dengue patients with leukopenia to track both white blood cell and platelet counts, according to Praxis Medical Insights 1
Monitor for warning signs of progression to severe disease, including severe abdominal pain 2, persistent vomiting 2, lethargy or restlessness 1, and mucosal bleeding 1
The cornerstone of management for dengue-associated leukopenia is supportive care, as there is no specific antiviral therapy currently approved, according to Praxis Medical Insights 1
Ensure adequate hydration with oral rehydration for patients without signs of shock, as recommended by Praxis Medical Insights 1
Acetaminophen (paracetamol) at standard doses is recommended for pain and fever management 2
Avoid aspirin and other non-steroidal anti-inflammatory drugs due to increased bleeding risk in the setting of potential thrombocytopenia 1, 2
Avoid invasive procedures when possible during the acute phase of illness, especially if coagulopathy is present 3

In patients with severe dengue with warning signs or shock, prioritize fluid management according to established protocols, as recommended by Praxis Medical Insights 1
Avoid unnecessary prophylactic interventions for isolated leukopenia without clinical deterioration 1
Do not administer excessive fluid boluses in patients without shock, as this can lead to fluid overload and respiratory complications, according to Praxis Medical Insights 1
Avoid failing to recognize the critical phase when plasma leakage can rapidly progress to shock 1
Do not delay fluid resuscitation in patients who develop dengue shock syndrome 1